Paul Elliot Mann - Net Worth and Insider Trading

Paul Elliot Mann Net Worth

The estimated net worth of Paul Elliot Mann is at least $516 dollars as of 2024-05-17. Paul Elliot Mann is the CFO of Regenetp Inc and owns about 16,638 shares of Regenetp Inc (RGTPQ) stock worth over $516. Paul Elliot Mann is also the Director of Abeona Therapeutics Inc and owns about 0 shares of Abeona Therapeutics Inc (ABEO) stock worth over $0. Details can be seen in Paul Elliot Mann's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul Elliot Mann has not made any transactions after 2021-02-19 and currently still holds the listed stock(s).

Transaction Summary of Paul Elliot Mann

To

Paul Elliot Mann Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul Elliot Mann owns 4 companies in total, including Abeona Therapeutics Inc (ABEO) , Regenetp Inc (RGTPQ) , and Healthtech Solutions Inc (HLTT) among others .

Click here to see the complete history of Paul Elliot Mann’s form 4 insider trades.

Insider Ownership Summary of Paul Elliot Mann

Ticker Comapny Transaction Date Type of Owner
ABEO Abeona Therapeutics Inc 2021-02-19 director
RGTPQ Regenetp Inc 2020-03-31 Chief Financial Officer
HLTT Healthtech Solutions Inc 2021-07-13 director
2022-11-09 director & 10 percent owner & Chief Executive Officer

Paul Elliot Mann Latest Holdings Summary

Paul Elliot Mann currently owns a total of 2 stocks. Among these stocks, Paul Elliot Mann owns 16,638 shares of Regenetp Inc (RGTPQ) as of March 31, 2020, with a value of $516 and a weighting of 100%. Paul Elliot Mann also owns 0 shares of Abeona Therapeutics Inc (ABEO) as of February 19, 2021, with a value of $0 and a weighting of 0%.

Latest Holdings of Paul Elliot Mann

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RGTPQ Regenetp Inc 2020-03-31 16,638 0.03 516
ABEO Abeona Therapeutics Inc 2021-02-19 0 4.52 0

Holding Weightings of Paul Elliot Mann


Paul Elliot Mann Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul Elliot Mann has made a total of 6 transactions in Regenetp Inc (RGTPQ) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Regenetp Inc is the sale of 926 shares on March 31, 2020, which brought Paul Elliot Mann around $24,084.

According to the SEC Form 4 filings, Paul Elliot Mann has made a total of 6 transactions in Abeona Therapeutics Inc (ABEO) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Abeona Therapeutics Inc is the sale of 1,823 shares on February 19, 2021, which brought Paul Elliot Mann around $108,447.

Insider Trading History of Paul Elliot Mann

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul Elliot Mann Trading Performance

GuruFocus tracks the stock performance after each of Paul Elliot Mann's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul Elliot Mann is -26.94%. GuruFocus also compares Paul Elliot Mann's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul Elliot Mann within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Paul Elliot Mann's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Paul Elliot Mann

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -15.44
Relative Return to S&P 500(%) -16.01

Paul Elliot Mann Ownership Network

Ownership Network List of Paul Elliot Mann

No Data

Ownership Network Relation of Paul Elliot Mann


Paul Elliot Mann Owned Company Details

What does Abeona Therapeutics Inc do?

Who are the key executives at Abeona Therapeutics Inc?

Paul Elliot Mann is the director of Abeona Therapeutics Inc. Other key executives at Abeona Therapeutics Inc include SVP & General Counsel Brendan M. O'malley , director & Chief Executive Officer Vishwas Seshadri , and Chief Financial Officer Joseph Walter Vazzano .

Abeona Therapeutics Inc (ABEO) Insider Trades Summary

Over the past 18 months, Paul Elliot Mann made no insider transaction in Abeona Therapeutics Inc (ABEO). Other recent insider transactions involving Abeona Therapeutics Inc (ABEO) include a net sale of 7,443 shares made by Michael Amoroso , a net purchase of 24,969 shares made by Brendan M. O'malley , and a net purchase of 50,000 shares made by Vishwas Seshadri .

In summary, during the past 3 months, insiders sold 0 shares of Abeona Therapeutics Inc (ABEO) in total and bought 31,758 shares, with a net purchase of 31,758 shares. During the past 18 months, 43,636 shares of Abeona Therapeutics Inc (ABEO) were sold and 93,627 shares were bought by its insiders, resulting in a net purchase of 49,991 shares.

Abeona Therapeutics Inc (ABEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Abeona Therapeutics Inc Insider Transactions

No Available Data

Paul Elliot Mann Mailing Address

Above is the net worth, insider trading, and ownership report for Paul Elliot Mann. You might contact Paul Elliot Mann via mailing address: C/o Asp Isotopes Inc., 433 Plaza Real, Suite 275, Boca Raton Fl 33432.

Discussions on Paul Elliot Mann

No discussions yet.